Analytics

rAAV vectorology is being optimised to allow for highly specific expression and greater efficacy – how is this being achieved, and why is it so important?

Recent developments in gene therapy and the approval of mrna vaccines for treating diseases has seen the biopharmaceutical industry’s need for more well-characterised rna and oligonucleotides than ever before. How are more nucleic acid sequences being analysed by mass spectrometry (ms) through the development of new technologies, and how can innovations in software process data fully automate the workflow of the confirmation of oligonucleotide sequences based on intact ms/ms

IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading

How are handheld Raman devices and process analysers helping to streamline Quality Control (QC) procedures and enable continuous manufacturing?

As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research

Innovations in cellular biochemistry are helping to bring better personalised medicine onto the market. How can trapped ion mass spectrometry (TIMS) support this moving forward?

What improvements could High Resolution Ion Mobility (HRIM) bring to separation ability, throughput and reproducibility, and researchers’ understanding of glycoprotein structures?

The ability to visualise in greater detail and with better accuracy can offer laboratories an array of benefits. What new developments are entering the industry, and how can they overcome obstacles to analysis?

Many elements make up the composition of topical pharmaceutical products, and maintaining the correct rheological characteristics is vital to avoid product quality and even failure.